2019-27954. Importer of Controlled Substances Application: Myoderm  

  • Start Preamble

    ACTION:

    Notice of application.

    DATES:

    Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before January 27, 2020. Such persons may also file a written request for a hearing on the application on or before January 27, 2020.

    ADDRESSES:

    Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.

    End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In accordance with 21 CFR 1301.34(a), this is notice that on October 14, 2019, Myoderm, 48 East Main Street, Norristown, Pennsylvania 19401-4915 applied to be registered as an importer of the following basic classes of controlled substances:

    Controlled substanceDrug codeSchedule
    Amphetamine1100II
    Lisdexamfetamine1205II
    Methylphenidate1724II
    Nabilone7379II
    Oxycodone9143II
    Hydromorphone9150II
    Hydrocodone9193II
    Morphine9300II
    Oxymorphone9652II
    Fentanyl9801II

    The company plans to import the listed controlled substances for clinical trials, research, and analytical purposes. Approval of permit applications will occur only when the registrant's business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of FDA approved or non-approved finished dosage forms for commercial sale.

    Start Signature

    Dated: November 13, 2019.

    William T. McDermott,

    Acting Assistant Administrator.

    End Signature End Supplemental Information

    [FR Doc. 2019-27954 Filed 12-26-19; 8:45 am]

    BILLING CODE 4410-09-P

Document Information

Published:
12/27/2019
Department:
Drug Enforcement Administration
Entry Type:
Notice
Action:
Notice of application.
Document Number:
2019-27954
Dates:
Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before January 27, 2020. Such persons may also file a written request for a hearing on the application on or before January 27, 2020.
Pages:
71474-71474 (1 pages)
Docket Numbers:
Docket No. DEA-552
PDF File:
2019-27954.pdf